ctDNA assay detects colorectal cancer in blood

Circulating tumor DNA (ctDNA) assays can detect colorectal cancer (CRC) in blood samples with high specificity and sensitivity, according to a study published in . Annals of Oncology. ctDNA assays integrate genomics, epigenomics, and fragment-omics. The researchers tested the assay using blood samples taken from two groups of patients. The first group consisted of 318 […]
‘Weight loss’ has no negative impact on the quality of life of colorectal cancer patients

October 16, 2023 2 minute read Add topics to email alerts Receive an email when a new article is posted Enter your email address to receive emails when new articles are posted. . ” data-action=”subscribe”> Subscribe Your request could not be processed. Please try again later. If you continue to experience […]
Multidisciplinary care to advance metastatic colorectal cancer treatment

asthma atopic dermatitis autoimmune biosimilar breast cancer COPD COVID-19 (new coronavirus infection) cardiovascular bile duct cancer chronic kidney disease colorectal cancer DLBCL Dermatology Diabetes digital health Duchenne muscular dystrophy employer epilepsy gene therapy HIV heart failure hemophilia tumor immunology Infection inflammation leukemia and lymphoma liver lung cancer lupus major depressive disorder medicare multiple myeloma multiple […]
Targeted Oncology Metastatic Colorectal Cancer: Treatment Strategies and Hope for Patients An expert perspective on comprehensive treatment strategies for metastatic colorectal cancer, including systemic therapy, precision medicine….50 minutes ago

Targeted Oncology Metastatic Colorectal Cancer: Treatment Strategies and Hope for Patients An expert perspective on comprehensive treatment strategies for metastatic colorectal cancer, including systemic therapy, precision medicine….50 minutes ago
First rectal cancer patient in Delaware receives new radiation-free treatment

September 16, 2023 John Taylor is a man who fixes things. The 63-year-old has had a long career in maintenance and uses his know-how to help others. But his rectal cancer diagnosis left him incurable. “My most important job is to take care of my wife, Sharon, who has Parkinson’s disease,” Taylor said. “I couldn’t […]
This woman’s colon cancer disappeared after taking a new drug for six months.

The 42-year-old woman had no evidence of cancer after receiving dostarimab, a drug still in early trials to treat a rare form of colorectal cancer. advertisement Carrie Downey, a single mother with a 17-year-old son, was diagnosed with colon cancer a year ago, but after just six months of treatment with a new anti-cancer drug, […]
Foods that may lower your risk of colon cancer – Cleveland Clinic

If what you eat determines your body, it’s important to eat healthily. Cleveland Clinic is a nonprofit academic medical center. Advertising on our site helps support our mission. We do not endorse any non-Cleveland Clinic products or services.policy If you are at high risk of developing the disease colon cancer, certain lifestyle habits can help […]
Cancer is not fair!

Illness brings families closer together. When she came back from one of her many hospital stays, I was asked to be her caregiver. I was a freelance writer at the time, and one summer in the late 1990s, I agreed to spend the night at her house. I have seen up close the horrific effects […]
PTEN-induced kinase 1 gene single nucleotide variant as a biomarker in adjuvant chemotherapy for colorectal cancer: a retrospective study | BMC Gastroenterology

tissue sample A total of 84 analytical samples were collected from surgical or biopsy specimens from 84 patients who underwent radical surgery for colorectal cancer at Saitama Medical University International Medical Center from January to December 2016. One case was excluded because the sample was too small. Therefore, we used metastatic lymph nodes instead of […]
Motixafortide shows efficacy as primary treatment for pancreatic cancer in phase 2 trial

Pancreas image | Image credit: © Лилия Захарчук – Stock.adobe.com Motixafortide, a CXC4 inhibitor, when combined with the PD-1 inhibitor cemiplimab and the standard of care (SoC) chemotherapy treatment gemcitabine and nab-paclitaxel (MCGN) Phase 2 Data from the CheMo4METPANC trial (NCT04543071) showed some positive results against (mPDAC). This data, presented as an abstract as part […]